SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 219.22 |
| Enterprise Value ($M) | 571.22 |
| Book Value ($M) | -338.38 |
| Book Value / Share | -4.85 |
| Price / Book | -0.65 |
| NCAV ($M) | -367.68 |
| NCAV / Share | -5.27 |
| Price / NCAV | -0.60 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.53 |
| Return on Assets (ROA) | -0.97 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.54 |
| Current Ratio | 3.58 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 264.90 |
| Assets | 294.21 |
| Liabilities | 632.58 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 55.25 |
| Operating Income | -277.47 |
| Net Income | -334.33 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -266.77 |
| Cash from Investing | -0.14 |
| Cash from Financing | 182.77 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | BlackRock, Inc. | 4.60 | 3.32 | |
| 13G/A | Prudential Financial Inc | 11.00 | ||
| 13G | Jennison Associates Llc | 10.40 | ||
| 13D/A | Frazier Life Sciences Public Fund, L.P. | 18.00 | 25.75 | |
| 13D/A | Takeda Pharmaceutical Co Ltd | 4.80 | -11.50 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A (Amendment No. 1) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 1) | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 4,153,193 | 12,423,781 | 33.43 | |
| 538,980 | 1,794,045 | 30.04 | |
| 339,280 | 1,965,709 | 17.26 | |
| 494,722 | 2,190,622 | 22.58 | |
| 550,163 | 2,417,140 | 22.76 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PCVX – Vaxcyte, Inc. | PEPG – PepGen Inc. |
| PGEN – Precigen, Inc. | PHVS – Pharvaris N.V. |
| PLRX – Pliant Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io